Tumor suppressive pathways in the control of neurogenesis

Cellular and Molecular Life Sciences

Volumn 70, Issue 4, 2013, Pages 581-597

  Bartesaghi, Stefano ^a   Salomoni, Paolo ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Neurogenesis; Stem cells; Transformation; Tumor suppressor

Indexed keywords

BMI1 PROTEIN; CYCLIN DEPENDENT KINASE; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN;

APOPTOSIS; AUTOPHAGY; BRAIN CANCER; BRAIN REGION; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; DNA REPLICATION; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; GENE FUNCTION; GENE INACTIVATION; MALIGNANT TRANSFORMATION; MEDULLOBLASTOMA; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PATHOGENESIS; PML GENE; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RB GENE; RETINOBLASTOMA; REVIEW; S PHASE CELL CYCLE CHECKPOINT; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; NEURAL STEM CELLS; NEUROGENESIS; POLYCOMB-GROUP PROTEINS; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84873630132     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-1063-9     Document Type: Review

References (241)

1. Gage FH (2000) Mammalian neural stem cells. Science 287(5457):1433-1438
2. Imayoshi I, Sakamoto M, Ohtsuka T, Kageyama R (2009) Continuous neurogenesis in the adult brain. Dev Growth Differ 51(3):379-386. doi: 10.1111/j.1440-169X.2009.01094.x
3. Imayoshi I, Sakamoto M, Ohtsuka T, Takao K, Miyakawa T, Yamaguchi M, Mori K, Ikeda T, Itohara S, Kageyama R (2008) Roles of continuous neurogenesis in the structural and functional integrity of the adult forebrain. Nat Neurosci 11(10):1153-1161. doi: 10.1038/nn.2185
4. Kriegstein A, Alvarez-Buylla A (2009) The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci 32:149-184. doi: 10.1146/annurev. neuro.051508.135600
5. Ming GL, Song H (2005) Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci 28:223-250. doi: 10.1146/annurev.neuro.28. 051804.101459
6. Temple S (2001) The development of neural stem cells. Nature 414(6859):112-117. doi: 10.1038/35102174
7. Gotz M, Huttner WB (2005) The cell biology of neurogenesis. Nat Rev Mol Cell Biol 6(10):777-788. doi: 10.1038/nrm1739
8. Lange C, Calegari F (2010) Cdks and cyclins link G1 length and differentiation of embryonic, neural and hematopoietic stem cells. Cell Cycle 9(10):1893-1900
9. Lange C, Huttner WB, Calegari F (2009) Cdk4/cyclinD1 overexpression in neural stem cells shortens G1, delays neurogenesis, and promotes the generation and expansion of basal progenitors. Cell Stem Cell 5(3):320-331. doi: 10.1016/j.stem.2009.05.026
10. Miller FD, Gauthier-Fisher A (2009) Home at last: neural stem cell niches defined. Cell Stem Cell 4(6):507-510. doi: 10.1016/j.stem.2009.05.008
11. Salomoni P, Calegari F (2010) Cell cycle control of mammalian neural stem cells: putting a speed limit on G1. Trends Cell Biol 20(5):233-243. doi: 10.1016/j.tcb.2010.01.006
12. Kempermann G, Kuhn HG, Gage FH (1997) Genetic influence on neurogenesis in the dentate gyrus of adult mice. Proc Natl Acad Sci USA 94(19):10409-10414
13. Reynolds BA, Weiss S (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255(5052):1707-1710
14. Richards LJ, Kilpatrick TJ, Bartlett PF (1992) De novo generation of neuronal cells from the adult mouse brain. Proc Natl Acad Sci USA 89(18):8591-8595
15. Lee A, Kessler JD, Read TA, Kaiser C, Corbeil D, Huttner WB, Johnson JE, Wechsler-Reya RJ (2005) Isolation of neural stem cells from the postnatal cerebellum. Nat Neurosci 8(6):723-729. doi: 10.1038/nn1473
16. Lie DC, Dziewczapolski G, Willhoite AR, Kaspar BK, Shults CW, Gage FH (2002) The adult substantia nigra contains progenitor cells with neurogenic potential. J Neurosci 22(15):6639-6649. doi: 20026700
17. Zhao M, Momma S, Delfani K, Carlen M, Cassidy RM, Johansson CB, Brismar H, Shupliakov O, Frisen J, Janson AM (2003) Evidence for neurogenesis in the adult mammalian substantia nigra. Proc Natl Acad Sci USA 100(13):7925-7930. doi: 10.1073/pnas.1131955100
18. Amato MA, Arnault E, Perron M (2004) Retinal stem cells in vertebrates: parallels and divergences. Int J Dev Biol 48(8-9):993-1001. doi: 10.1387/ijdb.041879ma
19. Raymond PA, Barthel LK, Bernardos RL, Perkowski JJ (2006) Molecular characterization of retinal stem cells and their niches in adult zebrafish. BMC Dev Biol 6:36. doi: 10.1186/1471-213X-6-36
20. He S, Nakada D, Morrison SJ (2009) Mechanisms of stem cell self-renewal. Annu Rev Cell Dev Biol 25:377-406. doi: 10.1146/annurev.cellbio.042308.113248
21. Zhao T, Xu Y (2010) p53 and stem cells: new developments and new concerns. Trends Cell Biol 20(3):170-175. doi: 10.1016/j.tcb.2009.12.004
22. Hong Y, Cervantes RB, Stambrook PJ (2006) DNA damage response and mutagenesis in mouse embryonic stem cells. Methods Mol Biol 329:313-326. doi: 10.1385/1-59745-037-5:313
23. Hong Y, Cervantes RB, Tichy E, Tischfield JA, Stambrook PJ (2007) Protecting genomic integrity in somatic cells and embryonic stem cells. Mutat Res 614(1-2):48-55. doi: 10.1016/j.mrfmmm.2006.06.006
24. Krtolica A (2005) Stem cell: balancing aging and cancer. Int J Biochem Cell Biol 37(5):935-941. doi: 10.1016/j.biocel.2004.10.007
25. Cunningham JJ, Roussel MF (2001) Cyclin-dependent kinase inhibitors in the development of the central nervous system. Cell Growth Differ 12(8):387-396
26. Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A (1999) Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97(6):703-716
27. Doetsch F, Petreanu L, Caille I, Garcia-Verdugo JM, Alvarez-Buylla A (2002) EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells. Neuron 36(6):1021-1034
28. Ming GL, Song H (2011) Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron 70(4):687-702. doi: 10.1016/j.neuron.2011.05.001
29. Alvarez-Buylla A, Lim DA (2004) For the long run: maintaining germinal niches in the adult brain. Neuron 41(5):683-686
30. Mirzadeh Z, Merkle FT, Soriano-Navarro M, Garcia-Verdugo JM, Alvarez-Buylla A (2008) Neural stem cells confer unique pinwheel architecture to the ventricular surface in neurogenic regions of the adult brain. Cell Stem Cell 3(3):265-278. doi: 10.1016/j.stem.2008.07.004
31. Shen Q, Wang Y, Kokovay E, Lin G, Chuang SM, Goderie SK, Roysam B, Temple S (2008) Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions. Cell Stem Cell 3(3):289-300. doi: 10.1016/j.stem.2008.07.026
32. Tavazoie M, Van der Veken L, Silva-Vargas V, Louissaint M, Colonna L, Zaidi B, Garcia-Verdugo JM, Doetsch F (2008) A specialized vascular niche for adult neural stem cells. Cell Stem Cell 3(3):279-288. doi: 10.1016/j.stem.2008. 07.025
33. Doetsch F (2003) The glial identity of neural stem cells. Nat Neurosci 6(11):1127-1134. doi: 10.1038/nn1144
34. Malumbres M, Barbacid M (2005) Mammalian cyclin-dependent kinases. Trends Biochem Sci 30(11):630-641. doi: 10.1016/j.tibs.2005.09.005
35. Wuarin J, Nurse P (1996) Regulating S phase: CDKs, licensing and proteolysis. Cell 85(6):785-787
36. Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13(12):1501-1512
37. Besson A, Dowdy SF, Roberts JM (2008) CDK inhibitors: cell cycle regulators and beyond. Dev Cell 14(2):159-169. doi: 10.1016/j.devcel.2008.01.013
38. Santamaria D, Ortega S (2006) Cyclins and CDKS in development and cancer: lessons from genetically modified mice. Front Biosci 11:1164-1188
39. Bally-Cuif L, Hammerschmidt M (2003) Induction and patterning of neuronal development, and its connection to cell cycle control. Curr Opin Neurobiol 13(1):16-25
40. Dehay C, Kennedy H (2007) Cell-cycle control and cortical development. Nat Rev Neurosci 8(6):438-450. doi: 10.1038/nrn2097
41. Durand B, Raff M (2000) A cell-intrinsic timer that operates during oligodendrocyte development. BioEssays 22(1):64-71. doi: 10.1002/(SICI)1521- 1878(200001)22:1<64:AID-BIES11>3.0.CO;2-Q
42. Belachew S, Aguirre AA, Wang H, Vautier F, Yuan X, Anderson S, Kirby M, Gallo V (2002) Cyclin-dependent kinase-2 controls oligodendrocyte progenitor cell cycle progression and is downregulated in adult oligodendrocyte progenitors. J Neurosci 22(19):8553-8562
43. Ferguson KL, Callaghan SM, O'Hare MJ, Park DS, Slack RS (2000) The Rb-CDK4/6 signaling pathway is critical in neural precursor cell cycle regulation. J Biol Chem 275(43):33593-33600. doi: 10.1074/jbc.M004879200
44. Vandenbosch R, Borgs L, Beukelaers P, Foidart A, Nguyen L, Moonen G, Berthet C, Kaldis P, Gallo V, Belachew S, Malgrange B (2007) CDK2 is dispensable for adult hippocampal neurogenesis. Cell Cycle 6(24):3065-3069
45. Artegiani B, Lindemann D, Calegari F (2011) Overexpression of cdk4 and cyclinD1 triggers greater expansion of neural stem cells in the adult mouse brain. J Exp Med 208(5):937-948. doi: 10.1084/jem.20102167
46. Beukelaers P, Vandenbosch R, Caron N, Nguyen L, Belachew S, Moonen G, Kiyokawa H, Barbacid M, Santamaria D, Malgrange B (2011) Cdk6-dependent regulation of G(1) length controls adult neurogenesis. Stem Cells 29(4):713-724. doi: 10.1002/stem.616
47. Lane DP, Crawford LV (1979) T antigen is bound to a host protein in SV40-transformed cells. Nature 278(5701):261-263
48. Linzer DI, Maltzman W, Levine AJ (1979) The SV40 A gene product is required for the production of a 54,000 MW cellular tumor antigen. Virology 98(2):308-318
49. Prives C (1998) Signaling to p53: breaking the MDM2-p53 circuit. Cell 95(1):5-8
50. Attardi LD, Jacks T (1999) The role of p53 in tumour suppression: lessons from mouse models. Cell Mol Life Sci 55(1):48-63
51. Isobe M, Emanuel BS, Givol D, Oren M, Croce CM (1986) Localization of gene for human p53 tumour antigen to band 17p13. Nature 320(6057):84-85. doi: 10.1038/320084a0
52. Jacks T (1996) Lessons from the p53 mutant mouse. J Cancer Res Clin Oncol 122(6):319-327
53. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B (1991) Identification of p53 as a sequence-specific DNA-binding protein. Science 252(5013):1708-1711
54. Matlashewski G, Lamb P, Pim D, Peacock J, Crawford L, Benchimol S (1984) Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene. EMBO J 3(13):3257-3262
55. McBride OW, Merry D, Givol D (1986) The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc Natl Acad Sci USA 83(1):130-134
56. Riley T, Sontag E, Chen P, Levine A (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9(5):402-412. doi: 10.1038/nrm2395
57. Green DR, Kroemer G (2009) Cytoplasmic functions of the tumour suppressor p53. Nature 458(7242):1127-1130. doi: 10.1038/nature07986
58. Belyi VA, Ak P, Markert E, Wang H, Hu W, Puzio-Kuter A, Levine AJ (2010) The origins and evolution of the p53 family of genes. Cold Spring Harb Perspect Biol 2(6):a001198. doi: 10.1101/cshperspect.a001198
59. Lane D, Levine A (2010) p53 Research: the past thirty years and the next thirty years. Cold Spring Harb Perspect Biol 2(12):a000893. doi: 10.1101/cshperspect.a000893
60. Mills AA (2005) p53: link to the past, bridge to the future. Genes Dev 19(18):2091-2099. doi: 10.1101/gad.1362905
61. Vousden KH, Ryan KM (2009) p53 and metabolism. Nat Rev Cancer 9(10):691-700. doi: 10.1038/nrc2715
62. Maiuri MC, Galluzzi L, Morselli E, Kepp O, Malik SA, Kroemer G (2010) Autophagy regulation by p53. Curr Opin Cell Biol 22(2):181-185. doi: 10.1016/j.ceb.2009.12.001
63. Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR, Gasco M, Garrone O, Crook T, Ryan KM (2006) DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126(1):121-134. doi: 10.1016/j.cell.2006.05.034
64. Miller FD, Pozniak CD, Walsh GS (2000) Neuronal life and death: an essential role for the p53 family. Cell Death Differ 7(10):880-888. doi: 10.1038/sj.cdd.4400736
65. Meletis K, Wirta V, Hede SM, Nister M, Lundeberg J, Frisen J (2006) p53 suppresses the self-renewal of adult neural stem cells. Development 133(2):363-369. doi: 10.1242/dev.02208
66. van Lookeren Campagne M, Gill R (1998) Tumor-suppressor p53 is expressed in proliferating and newly formed neurons of the embryonic and postnatal rat brain: comparison with expression of the cell cycle regulators p21Waf1/Cip1, p27Kip1, p57Kip2, p16Ink4a, cyclin G1, and the proto-oncogene Bax. J Comp Neurol 397(2):181-198
67. Poulaki V, Benekou A, Bozas E, Bolaris S, Stylianopoulou F (1999) p53 expression and regulation by NMDA receptors in the developing rat brain. J Neurosci Res 56(4):427-440
68. Rinon A, Molchadsky A, Nathan E, Yovel G, Rotter V, Sarig R, Tzahor E (2011) p53 coordinates cranial neural crest cell growth and epithelial- mesenchymal transition/delamination processes. Development 138(9):1827-1838. doi: 10.1242/dev.053645
69. Armstrong JF, Kaufman MH, Harrison DJ, Clarke AR (1995) High-frequency developmental abnormalities in p53-deficient mice. Curr Biol 5(8):931-936
70. Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT, Jacks T (1995) A subset of p53-deficient embryos exhibit exencephaly. Nat Genet 10(2):175-180. doi: 10.1038/ng0695-175
71. De Laurenzi V, Melino G (2000) Evolution of functions within the p53/p63/p73 family. Ann NY Acad Sci 926:90-100
72. Dotsch V, Bernassola F, Coutandin D, Candi E, Melino G (2010) p63 and p73, the ancestors of p53. Cold Spring Harb Perspect Biol 2(9):a004887. doi: 10.1101/cshperspect.a004887
73. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M (1999) The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397(6715):164-168. doi: 10.1038/16476
74. Levrero M, De Laurenzi V, Costanzo A, Gong J, Melino G, Wang JY (1999) Structure, function and regulation of p63 and p73. Cell Death Differ 6(12):1146-1153
75. Levrero M, De Laurenzi V, Costanzo A, Gong J, Wang JY, Melino G (2000) The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J Cell Sci 113(Pt 10):1661-1670
76. Gil-Perotin S, Marin-Husstege M, Li J, Soriano-Navarro M, Zindy F, Roussel MF, Garcia-Verdugo JM, Casaccia-Bonnefil P (2006) Loss of p53 induces changes in the behaviour of subventricular zone cells: implication for the genesis of glial tumors. J Neurosci 26(4):1107-1116. doi: 10.1523/JNEUROSCI. 3970-05.2006
77. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75(4):817-825
78. Cheng T, Rodrigues N, Dombkowski D, Stier S, Scadden DT (2000) Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat Med 6(11):1235-1240. doi: 10.1038/81335
79. Doetsch F, Verdugo JM, Caille I, Alvarez-Buylla A, Chao MV, Casaccia-Bonnefil P (2002) Lack of the cell-cycle inhibitor p27Kip1 results in selective increase of transit-amplifying cells for adult neurogenesis. J Neurosci 22(6):2255-2264
80. Kippin TE, Martens DJ, van der Kooy D (2005) p21 loss compromises the relative quiescence of forebrain stem cell proliferation leading to exhaustion of their proliferation capacity. Genes Dev 19(6):756-767. doi: 10.1101/gad.1272305
81. Francoz S, Froment P, Bogaerts S, De Clercq S, Maetens M, Doumont G, Bellefroid E, Marine JC (2006) Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo. Proc Natl Acad Sci USA 103(9):3232-3237. doi: 10.1073/pnas.0508476103
82. Medrano S, Burns-Cusato M, Atienza MB, Rahimi D, Scrable H (2009) Regenerative capacity of neural precursors in the adult mammalian brain is under the control of p53. Neurobiol Aging 30(3):483-497. doi: 10.1016/j. neurobiolaging.2007.07.016
83. Pechnick RN, Zonis S, Wawrowsky K, Pourmorady J, Chesnokova V (2008) p21Cip1 restricts neuronal proliferation in the subgranular zone of the dentate gyrus of the hippocampus. Proc Natl Acad Sci USA 105(4):1358-1363. doi: 10.1073/pnas.0711030105
84. Li X, Tang X, Jablonska B, Aguirre A, Gallo V, Luskin MB (2009) p27(KIP1) regulates neurogenesis in the rostral migratory stream and olfactory bulb of the postnatal mouse. J Neurosci 29(9):2902-2914. doi: 10.1523/JNEUROSCI.4051-08. 2009
85. Miyazawa K, Himi T, Garcia V, Yamagishi H, Sato S, Ishizaki Y (2000) A role for p27/Kip1 in the control of cerebellar granule cell precursor proliferation. J Neurosci 20(15):5756-5763
86. Lee MH, Nikolic M, Baptista CA, Lai E, Tsai LH, Massague J (1996) The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons. Proc Natl Acad Sci USA 93(8):3259-3263
87. Nguyen L, Besson A, Heng JI, Schuurmans C, Teboul L, Parras C, Philpott A, Roberts JM, Guillemot F (2006) p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev 20(11):1511-1524. doi: 10.1101/gad.377106
88. Nguyen L, Besson A, Roberts JM, Guillemot F (2006) Coupling cell cycle exit, neuronal differentiation and migration in cortical neurogenesis. Cell Cycle 5(20):2314-2318
89. Gil-Perotin S, Haines JD, Kaur J, Marin-Husstege M, Spinetta MJ, Kim KH, Duran-Moreno M, Schallert T, Zindy F, Roussel MF, Garcia-Verdugo JM, Casaccia P (2011) Roles of p53 and p27(Kip1) in the regulation of neurogenesis in the murine adult subventricular zone. Eur J Neurosci 34(7):1040-1052. doi: 10.1111/j.1460-9568.2011.07836.x
90. Stambolic V, MacPherson D, Sas D, Lin Y, Snow B, Jang Y, Benchimol S, Mak TW (2001) Regulation of PTEN transcription by p53. Mol Cell 8(2):317-325
91. Chalhoub N, Zhu G, Zhu X, Baker SJ (2009) Cell type specificity of PI3K signaling in Pdk1- and Pten-deficient brains. Genes Dev 23(14):1619-1624. doi: 10.1101/gad.1799609
92. Zheng H, Ying H, Yan H, Kimmelman AC, Hiller DJ, Chen AJ, Perry SR, Tonon G, Chu GC, Ding Z, Stommel JM, Dunn KL, Wiedemeyer R, You MJ, Brennan C, Wang YA, Ligon KL, Wong WH, Chin L, DePinho RA (2008) p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 455(7216):1129-1133. doi: 10.1038/nature07443
93. Zheng H, Ying H, Yan H, Kimmelman AC, Hiller DJ, Chen AJ, Perry SR, Tonon G, Chu GC, Ding Z, Stommel JM, Dunn KL, Wiedemeyer R, You MJ, Brennan C, Wang YA, Ligon KL, Wong WH, Chin L, dePinho RA (2008) Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma. Cold Spring Harb Symp Quant Biol 73:427-437. doi: 10.1101/sqb.2008.73.047
94. Alcantara Llaguno S, Chen J, Kwon CH, Jackson EL, Li Y, Burns DK, Alvarez-Buylla A, Parada LF (2009) Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 15(1):45-56. doi: 10.1016/j.ccr.2008.12.006
95. Wang Y, Yang J, Zheng H, Tomasek GJ, Zhang P, McKeever PE, Lee EY, Zhu Y (2009) Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model. Cancer Cell 15(6):514-526. doi: 10.1016/j.ccr.2009.04.001
96. Liu C, Sage JC, Miller MR, Verhaak RG, Hippenmeyer S, Vogel H, Foreman O, Bronson RT, Nishiyama A, Luo L, Zong H (2011) Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell 146(2):209-221. doi: 10.1016/j.cell.2011.06.014
97. Schmale H, Bamberger C (1997) A novel protein with strong homology to the tumor suppressor p53. Oncogene 15(11):1363-1367. doi: 10.1038/sj.onc.1201500
98. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2(3):305-316
99. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90(4):809-819
100. Jost CA, Marin MC, Kaelin WG Jr (1997) p73 is a simian (correction of human) p53-related protein that can induce apoptosis. Nature 389(6647):191-194. doi: 10.1038/38298
101. Murray-Zmijewski F, Lane DP, Bourdon JC (2006) p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ 13(6):962-972. doi: 10.1038/sj.cdd.4401914
102. Talos F, Nemajerova A, Flores ER, Petrenko O, Moll UM (2007) p73 suppresses polyploidy and aneuploidy in the absence of functional p53. Mol Cell 27(4):647-659. doi: 10.1016/j.molcel.2007.06.036
103. Tomasini R, Tsuchihara K, Tsuda C, Lau SK, Wilhelm M, Ruffini A, Tsao MS, Iovanna JL, Jurisicova A, Melino G, Mak TW (2009) TAp73 regulates the spindle assembly checkpoint by modulating BubR1 activity. Proc Natl Acad Sci USA 106(3):797-802. doi: 10.1073/pnas.0812096106
104. Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung CC, Khan F, Itie-Youten A, Wakeham A, Tsao MS, Iovanna JL, Squire J, Jurisica I, Kaplan D, Melino G, Jurisicova A, Mak TW (2008) TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev 22(19):2677-2691. doi: 10.1101/gad.1695308
105. Fillippovich I, Sorokina N, Gatei M, Haupt Y, Hobson K, Moallem E, Spring K, Mould M, McGuckin MA, Lavin MF, Khanna KK (2001) Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53. Oncogene 20(4):514-522. doi: 10.1038/sj.onc.1204118
106. Pozniak CD, Radinovic S, Yang A, McKeon F, Kaplan DR, Miller FD (2000) An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science 289(5477):304-306
107. Ravni A, Tissir F, Goffinet AM (2010) DeltaNp73 transcription factors modulate cell survival and tumor development. Cell Cycle 9(8):1523-1527
108. Tissir F, Ravni A, Achouri Y, Riethmacher D, Meyer G, Goffinet AM (2009) DeltaNp73 regulates neuronal survival in vivo. Proc Natl Acad Sci USA 106(39):16871-16876. doi: 10.1073/pnas.0903191106
109. Yang A, McKeon F (2000) P63 and P73: P53 mimics, menaces and more. Nat Rev Mol Cell Biol 1(3):199-207. doi: 10.1038/35043127
110. Irwin MS, Kaelin WG Jr (2001) Role of the newer p53 family proteins in malignancy. Apoptosis 6(1-2):17-29
111. Flores ER, Tsai KY, Crowley D, Sengupta S, Yang A, McKeon F, Jacks T (2002) p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 416(6880):560-564. doi: 10.1038/416560a
112. Flores ER, Sengupta S, Miller JB, Newman JJ, Bronson R, Crowley D, Yang A, McKeon F, Jacks T (2005) Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 7(4):363-373. doi: 10.1016/j.ccr.2005.02.019
113. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398(6729):708-713. doi: 10.1038/19531
114. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, Vagner C, Bonnet H, Dikkes P, Sharpe A, McKeon F, Caput D (2000) p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404(6773):99-103. doi: 10.1038/35003607
115. Agostini M, Tucci P, Killick R, Candi E, Sayan BS, di Val Rivetti, Cervo P, Nicotera P, McKeon F, Knight RA, Mak TW, Melino G (2011) Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets. Proc Natl Acad Sci USA 108(52):21093-21098. doi: 10.1073/pnas.1112061109
116. Fujitani M, Cancino GI, Dugani CB, Weaver IC, Gauthier-Fisher A, Paquin A, Mak TW, Wojtowicz MJ, Miller FD, Kaplan DR (2010) TAp73 acts via the bHLH Hey2 to promote long-term maintenance of neural precursors. Curr Biol 20(22):2058-2065. doi: 10.1016/j.cub.2010.10.029
117. Holembowski L, Schulz R, Talos F, Scheel A, Wolff S, Dobbelstein M, Moll U (2011) While p73 is essential, p63 is completely dispensable for the development of the central nervous system. Cell Cycle 10(4):680-689
118. Wilhelm MT, Rufini A, Wetzel MK, Tsuchihara K, Inoue S, Tomasini R, Itie-Youten A, Wakeham A, Arsenian-Henriksson M, Melino G, Kaplan DR, Miller FD, Mak TW (2010) Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway. Genes Dev 24(6):549-560. doi: 10.1101/gad.1873910
119. Packard A, Schnittke N, Romano RA, Sinha S, Schwob JE (2011) DeltaNp63 regulates stem cell dynamics in the mammalian olfactory epithelium. J Neurosci 31(24):8748-8759. doi: 10.1523/JNEUROSCI.0681-11.2011
120. Fletcher RB, Prasol MS, Estrada J, Baudhuin A, Vranizan K, Choi YG, Ngai J (2011) p63 regulates olfactory stem cell self-renewal and differentiation. Neuron 72(5):748-759. doi: 10.1016/j.neuron.2011.09.009
121. Dugani CB, Paquin A, Fujitani M, Kaplan DR, Miller FD (2009) p63 antagonizes p53 to promote the survival of embryonic neural precursor cells. J Neurosci 29(20):6710-6721. doi: 10.1523/JNEUROSCI.5878-08.2009
122. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323(6089):643-646. doi: 10.1038/323643a0
123. Fung YK, Murphree AL, T'Ang A, Qian J, Hinrichs SH, Benedict WF (1987) Structural evidence for the authenticity of the human retinoblastoma gene. Science 236(4809):1657-1661
124. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY (1987) Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235(4794):1394-1399
125. Weinberg RA (1991) Tumor suppressor genes. Science 254(5035):1138-1146
126. Blanquet V, Turleau C, Gross MS, Goossens M, Besmond C (1993) Identification of germline mutations in the RB1 gene by denaturant gradient gel electrophoresis and polymerase chain reaction direct sequencing. Hum Mol Genet 2(7):975-979
127. Classon M, Harlow E (2002) The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2(12):910-917. doi: 10.1038/nrc950
128. Dyer MA, Bremner R (2005) The search for the retinoblastoma cell of origin. Nat Rev Cancer 5(2):91-101. doi: 10.1038/nrc1545
129. Egan C, Bayley ST, Branton PE (1989) Binding of the Rb1 protein to E1A products is required for adenovirus transformation. Oncogene 4(3):383-388
130. Harbour JW, Lai SL, Whang-Peng J, Gazdar AF, Minna JD, Kaye FJ (1988) Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241(4863):353-357
131. Horowitz JM, Park SH, Bogenmann E, Cheng JC, Yandell DW, Kaye FJ, Minna JD, Dryja TP, Weinberg RA (1990) Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci USA 87(7):2775-2779
132. Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, Harlow E (1988) Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334(6178):124-129. doi: 10.1038/334124a0
133. DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, Marsilio E, Paucha E, Livingston DM (1988) SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54(2):275-283
134. Dyson N, Howley PM, Munger K, Harlow E (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243(4893):934-937
135. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM (1989) Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. Embo J 8(13):4099-4105
136. Hu QJ, Dyson N, Harlow E (1990) The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. Embo J 9(4):1147-1155
137. Harbour JW, Dean DC (2000) Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol 2(4):E65-E67. doi: 10.1038/35008695
138. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81(3):323-330
139. Buchkovich K, Duffy LA, Harlow E (1989) The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58(6):1097-1105
140. Cooper S, Shayman JA (2001) Revisiting retinoblastoma protein phosphorylation during the mammalian cell cycle. Cell Mol Life Sci 58(4):580-595
141. Luo RX, Postigo AA, Dean DC (1998) Rb interacts with histone deacetylase to repress transcription. Cell 92(4):463-473
142. Coschi CH, Martens AL, Ritchie K, Francis SM, Chakrabarti S, Berube NG, Dick FA (2010) Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive. Genes Dev 24(13):1351-1363. doi: 10.1101/gad.1917610
143. Manning AL, Dyson NJ (2012) RB: mitotic implications of a tumour suppressor. Nat Rev Cancer 12(3):220-226. doi: 10.1038/nrc3216
144. van Harn T, Foijer F, van Vugt M, Banerjee R, Yang F, Oostra A, Joenje H, te Riele H (2010) Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling. Genes Dev 24(13):1377-1388. doi: 10.1101/gad.580710
145. Sage J, Straight AF (2010) RB's original CIN? Genes Dev 24(13):1329-1333. doi: 10.1101/gad.1948010
146. Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, Hooper ML, Berns A, te Riele H (1992) Requirement for a functional Rb-1 gene in murine development. Nature 359(6393):328-330. doi: 10.1038/359328a0
147. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an Rb mutation in the mouse. Nature 359(6393):295-300. doi: 10.1038/359295a0
148. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A (1992) Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359(6393):288-294. doi: 10.1038/359288a0
149. Zacksenhaus E, Jiang Z, Chung D, Marth JD, Phillips RA, Gallie BL (1996) pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev 10(23):3051-3064
150. Lee EY, Hu N, Yuan SS, Cox LA, Bradley A, Lee WH, Herrup K (1994) Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev 8(17):2008-2021
151. Lipinski MM, Macleod KF, Williams BO, Mullaney TL, Crowley D, Jacks T (2001) Cell-autonomous and non-cell-autonomous functions of the Rb tumor suppressor in developing central nervous system. Embo J 20(13):3402-3413. doi: 10.1093/emboj/20.13.3402
152. Ferguson KL, Vanderluit JL, Hebert JM, McIntosh WC, Tibbo E, MacLaurin JG, Park DS, Wallace VA, Vooijs M, McConnell SK, Slack RS (2002) Telencephalon-specific Rb knockouts reveal enhanced neurogenesis, survival and abnormal cortical development. Embo J 21(13):3337-3346. doi: 10.1093/emboj/cdf338
153. MacPherson D, Sage J, Kim T, Ho D, McLaughlin ME, Jacks T (2004) Cell type-specific effects of Rb deletion in the murine retina. Genes Dev 18(14):1681-1694. doi: 10.1101/gad.1203304
154. Marino S, Hoogervoorst D, Brandner S, Berns A (2003) Rb and p107 are
155. Ferguson KL, McClellan KA, Vanderluit JL, McIntosh WC, Schuurmans C, Polleux F, Slack RS (2005) A cell-autonomous requirement for the cell cycle regulatory protein, Rb, in neuronal migration. Embo J 24(24):4381-4391. doi: 10.1038/sj.emboj.7600887
156. Ewen ME, Faha B, Harlow E, Livingston DM (1992) Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science 255(5040):85-87
157. Ewen ME, Xing YG, Lawrence JB, Livingston DM (1991) Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66(6):1155-1164
158. Hannon GJ, Demetrick D, Beach D (1993) Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev 7(12A):2378-2391
159. Li Y, Graham C, Lacy S, Duncan AM, Whyte P (1993) The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 7(12A):2366-2377
160. Mayol X, Grana X, Baldi A, Sang N, Hu Q, Giordano A (1993) Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene 8(9):2561-2566
161. Cobrinik D (2005) Pocket proteins and cell cycle control. Oncogene 24(17):2796-2809. doi: 10.1038/sj.onc.1208619
162. Trimarchi JM, Lees JA (2002) Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 3(1):11-20. doi: 10.1038/nrm714
163. Mulligan G, Jacks T (1998) The retinoblastoma gene family: cousins with overlapping interests. Trends Genet 14(6):223-229
164. Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, Harlow E, Beach D, Weinberg RA, Jacks T (1996) Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev 10(13):1633-1644
165. Lee MH, Williams BO, Mulligan G, Mukai S, Bronson RT, Dyson N, Harlow E, Jacks T (1996) Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev 10(13):1621-1632
166. Callaghan DA, Dong L, Callaghan SM, Hou YX, Dagnino L, Slack RS (1999) Neural precursor cells differentiating in the absence of Rb exhibit delayed terminal mitosis and deregulated E2F 1 and 3 activity. Dev Biol 207(2):257-270. doi: 10.1006/dbio.1998.9162
167. Donovan SL, Schweers B, Martins R, Johnson D, Dyer MA (2006) Compensation by tumor suppressor genes during retinal development in mice and humans. BMC Biol 4:14. doi: 10.1186/1741-7007-4-14
168. Ajioka I, Martins RA, Bayazitov IT, Donovan S, Johnson DA, Frase S, Cicero SA, Boyd K, Zakharenko SS, Dyer MA (2007) Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice. Cell 131(2):378-390. doi: 10.1016/j.cell.2007.09.036
169. Xu XL, Fang Y, Lee TC, Forrest D, Gregory-Evans C, Almeida D, Liu A, Jhanwar SC, Abramson DH, Cobrinik D (2009) Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling. Cell 137(6):1018-1031. doi: 10.1016/j.cell.2009.03.051
170. Jacques TS, Swales A, Brzozowski MJ, Henriquez NV, Linehan JM, Mirzadeh Z, O'Malley C, Naumann H, Alvarez-Buylla A, Brandner S (2010) Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes. Embo J 29(1):222-235. doi: 10.1038/emboj.2009.327
171. Marino S, Vooijs M, van Der Gulden H, Jonkers J, Berns A (2000) Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev 14(8):994-1004
172. Xiao A, Wu H, Pandolfi PP, Louis DN, Van Dyke T (2002) Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Cancer Cell 1(2):157-168
173. Vanderluit JL, Ferguson KL, Nikoletopoulou V, Parker M, Ruzhynsky V, Alexson T, McNamara SM, Park DS, Rudnicki M, Slack RS (2004) p107 regulates neural precursor cells in the mammalian brain. J Cell Biol 166(6):853-863. doi: 10.1083/jcb.200403156
174. Vanderluit JL, Wylie CA, McClellan KA, Ghanem N, Fortin A, Callaghan S, MacLaurin JG, Park DS, Slack RS (2007) The Retinoblastoma family member p107 regulates the rate of progenitor commitment to a neuronal fate. J Cell Biol 178(1):129-139. doi: 10.1083/jcb.200703176
175. McClellan KA, Vanderluit JL, Julian LM, Andrusiak MG, Dugal-Tessier D, Park DS, Slack RS (2009) The p107/E2F pathway regulates fibroblast growth factor 2 responsiveness in neural precursor cells. Mol Cell Biol 29(17):4701-4713. doi: 10.1128/MCB.01767-08
176. Borrow J, Goddard AD, Sheer D, Solomon E (1990) Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249(4976):1577-1580
177. de The H, Chomienne C, Lanotte M, Degos L, Dejean A (1990) The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347(6293):558-561. doi: 10.1038/347558a0
178. de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A (1991) The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66(4):675-684
179. Longo L, Pandolfi PP, Biondi A, Rambaldi A, Mencarelli A, Lo Coco F, Diverio D, Pegoraro L, Avanzi G, Tabilio A et al (1990) Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias. J Exp Med 172(6):1571-1575
180. Melnick A, Licht JD (1999) Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93(10):3167-3215
181. Pandolfi PP, Grignani F, Alcalay M, Mencarelli A, Biondi A, LoCoco F, Pelicci PG (1991) Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6(7):1285-1292
182. Kakizuka A, Miller WH Jr, Umesono K, Warrell RP Jr, Frankel SR, Murty VV, Dmitrovsky E, Evans RM (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66(4):663-674
183. Pandolfi PP, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, Diverio D, Biondi A, Lo Coco F, Rambaldi A, Grignani F et al (1992) Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia. Embo J 11(4):1397-1407
184. Salomoni P, Pandolfi PP (2002) The role of PML in tumor suppression. Cell 108(2):165-170
185. Wang ZG, Ruggero D, Ronchetti S, Zhong S, Gaboli M, Rivi R, Pandolfi PP (1998) PML is essential for multiple apoptotic pathways. Nat Genet 20(3):266-272. doi: 10.1038/3073
186. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T, Yeh ET, Strauss JF 3rd, Maul GG (1999) PML is critical for ND10 formation and recruits the PML-interacting protein DAXX to this nuclear structure when modified by SUMO-1. J Cell Biol 147(2):221-234
187. Lallemand-Breitenbach V, de The H (2010) PML nuclear bodies. Cold Spring Harb Perspect Biol 2(5):a000661. doi: 10.1101/cshperspect.a000661
188. Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP (2006) The mechanisms of PML-nuclear body formation. Mol Cell 24(3):331-339. doi: 10.1016/j.molcel.2006.09.013
189. Borden KL, Culjkovic B (2009) Perspectives in PML: a unifying framework for PML function. Front Biosci 14:497-509
190. Bourdeau V, Baudry D, Ferbeyre G (2009) PML links aberrant cytokine signaling and oncogenic stress to cellular senescence. Front Biosci 14:475-485
191. Hofmann TG, Will H (2003) Body language: the function of PML nuclear bodies in apoptosis regulation. Cell Death Differ 10(12):1290-1299. doi: 10.1038/sj.cdd.4401313
192. Pearson M, Pelicci PG (2001) PML interaction with p53 and its role in apoptosis and replicative senescence. Oncogene 20(49):7250-7256. doi: 10.1038/sj.onc.1204856
193. Salomoni P, Ferguson BJ, Wyllie AH, Rich T (2008) New insights into the role of PML in tumour suppression. Cell Res 18(6):622-640. doi: 10.1038/cr.2008.58
194. Takahashi Y, Lallemand-Breitenbach V, Zhu J, de The H (2004) PML nuclear bodies and apoptosis. Oncogene 23(16):2819-2824. doi: 10.1038/sj.onc.1207533
195. Regad T, Bellodi C, Nicotera P, Salomoni P (2009) The tumor suppressor PML regulates cell fate in the developing neocortex. Nat Neurosci 12(2):132-140. doi: 10.1038/nn.2251
196. Michod D, Bartesaghi S, Khelifi A, Bellodi C, Berliocchi L, Nicotera P, Salomoni P (2012) Calcium-dependent dephosphorylation of the histone chaperone DAXX regulates H3.3 loading and transcription upon neuronal activation. Neuron 74(1):122-135. doi: 10.1016/j.neuron.2012.02.021
197. Drane P, Ouararhni K, Depaux A, Shuaib M, Hamiche A (2010) The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes Dev 24(12):1253-1265. doi: 10.1101/gad.566910
198. Lewis PW, Elsaesser SJ, Noh KM, Stadler SC, Allis CD (2010) DAXX is an H3.3-specific histone chaperone and cooperates with ATRX in replication- independent chromatin assembly at telomeres. Proc Natl Acad Sci USA 107(32):14075-14080. doi: 10.1073/pnas.1008850107
199. Berube NG, Mangelsdorf M, Jagla M, Vanderluit J, Garrick D, Gibbons RJ, Higgs DR, Slack RS, Picketts DJ (2005) The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis. J Clin Invest 115(2):258-267. doi: 10.1172/JCI22329
200. Ito K, Bernardi R, Morotti A, Matsuoka S, Saglio G, Ikeda Y, Rosenblatt J, Avigan DE, Teruya-Feldstein J, Pandolfi PP (2008) PML targeting eradicates quiescent leukaemia-initiating cells. Nature 453(7198):1072-1078. doi: 10.1038/nature07016
201. Milyavsky M, Gan OI, Trottier M, Komosa M, Tabach O, Notta F, Lechman E, Hermans KG, Eppert K, Konovalova Z, Ornatsky O, Domany E, Meyn MS, Dick JE (2010) A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal. Cell Stem Cell 7(2):186-197. doi: 10.1016/j.stem.2010.05.016
202. Li W, Ferguson BJ, Khaled WT, Tevendale M, Stingl J, Poli V, Rich T, Salomoni P, Watson CJ (2009) PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. Proc Natl Acad Sci USA 106(12):4725-4730. doi: 10.1073/pnas.0807640106
203. Salomoni P, Betts-Henderson J (2011) The role of PML in the nervous system. Mol Neurobiol 43(2):114-123. doi: 10.1007/s12035-010-8156-y
204. Gurrieri C, Capodieci P, Bernardi R, Scaglioni PP, Nafa K, Rush LJ, Verbel DA, Cordon-Cardo C, Pandolfi PP (2004) Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J Natl Cancer Inst 96(4):269-279
205. Huse JT, Holland EC (2010) Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer 10(5):319-331. doi: 10.1038/nrc2818
206. Jeanne M, Lallemand-Breitenbach V, Ferhi O, Koken M, Le Bras M, Duffort S, Peres L, Berthier C, Soilihi H, Raught B, de The H (2010) PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3. Cancer Cell 18(1):88-98. doi: 10.1016/j.ccr.2010.06.003
207. Zhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB, Liang WX, Song AX, Lallemand-Breitenbach V, Jeanne M, Zhang QY, Yang HY, Huang QH, Zhou GB, Tong JH, Zhang Y, Wu JH, Hu HY, de The H, Chen SJ, Chen Z (2010) Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science 328(5975):240-243. doi: 10.1126/science.1183424
208. Alkema MJ, Wiegant J, Raap AK, Berns A, van Lohuizen M (1993) Characterization and chromosomal localization of the human proto-oncogene BMI-1. Hum Mol Genet 2(10):1597-1603
209. Tavares L, Dimitrova E, Oxley D, Webster J, Poot R, Demmers J, Bezstarosti K, Taylor S, Ura H, Koide H, Wutz A, Vidal M, Elderkin S, Brockdorff N (2012) RYBP-PRC1 complexes mediate H2A ubiquitylation at Polycomb target sites independently of PRC2 and H3 K27me3. Cell 148(4):664-678. doi: 10.1016/j.cell.2011.12.029
210. Shah N, Sukumar S (2010) The Hox genes and their roles in oncogenesis. Nat Rev Cancer 10(5):361-371. doi: 10.1038/nrc2826
211. Brookes E, de Santiago I, Hebenstreit D, Morris KJ, Carroll T, Xie SQ, Stock JK, Heidemann M, Eick D, Nozaki N, Kimura H, Ragoussis J, Teichmann SA, Pombo A (2012) Polycomb associates genome-wide with a specific RNA polymerase II variant, and regulates metabolic genes in ESCs. Cell Stem Cell 10(2):157-170. doi: 10.1016/j.stem.2011.12.017
212. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ (2003) Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425(6961):962-967. doi: 10.1038/nature02060
213. van der Lugt NM, Domen J, Linders K, van Roon M, Robanus-Maandag E, te Riele H, van der Valk M, Deschamps J, Sofroniew M, van Lohuizen M et al (1994) Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev 8(7):757-769
214. Quelle DE, Zindy F, Ashmun RA, Sherr CJ (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83(6):993-1000
215. Sharpless NE, DePinho RA (1999) The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev 9(1):22-30
216. Sherr CJ (2006) Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 6(9):663-673. doi: 10.1038/nrc1954
217. Park IK, Morrison SJ, Clarke MF (2004) Bmi1, stem cells, and senescence regulation. J Clin Invest 113(2):175-179. doi: 10.1172/JCI20800
218. Marine JC (2010) p53 stabilization: the importance of nuclear import. Cell Death Differ 17(2):191-192. doi: 10.1038/cdd.2009.183
219. Vonlanthen S, Heighway J, Altermatt HJ, Gugger M, Kappeler A, Borner MM, van Lohuizen M, Betticher DC (2001) The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer 84(10):1372-1376. doi: 10.1054/bjoc.2001.1791
220. Fasano CA, Dimos JT, Ivanova NB, Lowry N, Lemischka IR, Temple S (2007) shRNA knockdown of Bmi-1 reveals a critical role for p21-Rb pathway in NSC self-renewal during development. Cell Stem Cell 1(1):87-99. doi: 10.1016/j.stem.2007.04.001
221. Subkhankulova T, Zhang X, Leung C, Marino S (2010) Bmi1 directly represses p21Waf1/Cip1 in Shh-induced proliferation of cerebellar granule cell progenitors. Mol Cell Neurosci 45(2):151-162. doi: 10.1016/j.mcn.2010.06.006
222. Fasano CA, Phoenix TN, Kokovay E, Lowry N, Elkabetz Y, Dimos JT, Lemischka IR, Studer L, Temple S (2009) Bmi-1 cooperates with Foxg1 to maintain neural stem cell self-renewal in the forebrain. Genes Dev 23(5):561-574. doi: 10.1101/gad.1743709
223. Leung C, Lingbeek M, Shakhova O, Liu J, Tanger E, Saremaslani P, Van Lohuizen M, Marino S (2004) Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 428(6980):337-341. doi: 10.1038/nature02385
224. Marino S (2005) Medulloblastoma: developmental mechanisms out of control. Trends Mol Med 11(1):17-22. doi: 10.1016/j.molmed.2004.11.008
225. Alvarez-Buylla A, Kohwi M, Nguyen TM, Merkle FT (2008) The heterogeneity of adult neural stem cells and the emerging complexity of their niche. Cold Spring Harb Symp Quant Biol 73:357-365. doi: 10.1101/sqb.2008.73.019
226. Alvarez-Buylla A, Temple S (1998) Stem cells in the developing and adult nervous system. J Neurobiol 36(2):105-110
227. Morshead CM, Craig CG, van der Kooy D (1998) In vivo clonal analyses reveal the properties of endogenous neural stem cell proliferation in the adult mammalian forebrain. Development 125(12):2251-2261
228. Kruger GM, Mosher JT, Bixby S, Joseph N, Iwashita T, Morrison SJ (2002) Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness. Neuron 35(4):657-669
229. Molofsky AV, He S, Bydon M, Morrison SJ, Pardal R (2005) Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev 19(12):1432-1437. doi: 10.1101/gad.1299505
230. Liu J, Cao L, Chen J, Song S, Lee IH, Quijano C, Liu H, Keyvanfar K, Chen H, Cao LY, Ahn BH, Kumar NG, Rovira II, Xu XL, van Lohuizen M, Motoyama N, Deng CX, Finkel T (2009) Bmi1 regulates mitochondrial function and the DNA damage response pathway. Nature 459(7245):387-392. doi: 10.1038/nature08040
231. Chatoo W, Abdouh M, David J, Champagne MP, Ferreira J, Rodier F, Bernier G (2009) The Polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity. J Neurosci 29(2):529-542. doi: 10.1523/JNEUROSCI.5303-08.2009
232. Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, Hamaguchi I, Nomiyama K, Hosokawa K, Sakurada K, Nakagata N, Ikeda Y, Mak TW, Suda T (2004) Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431(7011):997-1002. doi: 10.1038/nature02989
233. Le Belle JE, Orozco NM, Paucar AA, Saxe JP, Mottahedeh J, Pyle AD, Wu H, Kornblum HI (2011) Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner. Cell Stem Cell 8(1):59-71. doi: 10.1016/j.stem.2010.11.028
234. Hayry V, Tynninen O, Haapasalo HK, Wolfer J, Paulus W, Hasselblatt M, Sariola H, Paetau A, Sarna S, Niemela M, Wartiovaara K, Nupponen NN (2008) Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours. Neuropathol Appl Neurobiol 34(5):555-563. doi: 10.1111/j.1365-2990.2008.00949.x
235. Tirabosco R, De Maglio G, Skrap M, Falconieri G, Pizzolitto S (2008) Expression of the Polycomb-group protein BMI1 and correlation with p16 in astrocytomas an immunohistochemical study on 80 cases. Pathol Res Pract 204(9):625-631. doi: 10.1016/j.prp.2008.02.007
236. Hayry V, Tanner M, Blom T, Tynninen O, Roselli A, Ollikainen M, Sariola H, Wartiovaara K, Nupponen NN (2008) Copy number alterations of the Polycomb gene BMI1 in gliomas. Acta Neuropathol 116(1):97-102. doi: 10.1007/s00401-008- 0376-0
237. Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J, Bernier G (2009) BMI1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci 29(28):8884-8896. doi: 10.1523/JNEUROSCI.0968-09.2009
238. Michael LE, Westerman BA, Ermilov AN, Wang A, Ferris J, Liu J, Blom M, Ellison DW, van Lohuizen M, Dlugosz AA (2008) Bmi1 is required for Hedgehog pathway-driven medulloblastoma expansion. Neoplasia 10(12):1343-1349 1345p following 1349
239. Wiederschain D, Chen L, Johnson B, Bettano K, Jackson D, Taraszka J, Wang YK, Jones MD, Morrissey M, Deeds J, Mosher R, Fordjour P, Lengauer C, Benson JD (2007) Contribution of Polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis. Mol Cell Biol 27(13):4968-4979. doi: 10.1128/MCB.02244-06
240. Bruggeman SW, Hulsman D, Tanger E, Buckle T, Blom M, Zevenhoven J, van Tellingen O, van Lohuizen M (2007) Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell 12(4):328-341. doi: 10.1016/j.ccr.2007.08.032
241. Dirks P (2007) Bmi1 and cell of origin determinants of brain tumor phenotype. Cancer Cell 12(4):295-297. doi: 10.1016/j.ccr.2007.10.003